abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Cash Flow Growth
-238.76%
TTM · Period ending:
HQL Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-238.76%period ending
Latest reported-238.76%period ending
HQL TTM Cash from Operations YoY % (-6.67% → -238.76%)
Year-over-year change
High-resolution chart · PNG
HQL operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -238.7596% | |
| 100% | |
| 50% | |
| 0% | |
| -9.1844% | |
| -20.2265% | |
| -10.1133% | |
| 0% | |
| -100% | |
| 100% | |
| 21.8437% | |
| 100% | |
| -3,383.8419% | |
| -16.0564% | |
| -100.0408% | |
| -100.2145% | |
| -94.8607% | |
| -84.8554% | |
| -41.0929% | |
| 15.9776% | |
| 101.6932% | |
| 706.7114% | |
| 240.3023% | |
| -39.9194% | |
| 20.6687% | |
| 206.1728% | |
| 1,330.4348% | |
| 239.6552% | |
| 120.7207% | |
| -9.434% | |
| 5.1282% | |
| 17.1875% | |
| 2.5% | |
| -14.2857% | |
| -13.2075% | |
| -12% | |
| -11.5789% | |
| -11.1111% | |
| 4.0404% | |
| -25% | |
| -45.5882% | |
| -6.6667% |